Results 181 to 190 of about 260,356 (192)

H-ferritin and proinflammatory cytokines are increased in the bone marrow of patients affected by macrophage activation syndrome

Clinical and Experimental Immunology, 2018
Piero Ruscitti, Paola Di Benedetto, Vasiliki Liakouli   +2 more
exaly  

Successful therapy of macrophage activation syndrome with dexamethasone palmitate

Modern Rheumatology, 2016
Yasuo Nakagishi, Masaki Shimizu, Akihiro Yachie   +2 more
exaly  

Successful treatment of macrophage activation syndrome in a patient with dermatomyositis by combination with immunosuppressive therapy and plasmapheresis

Modern Rheumatology, 2015
Shinjiro Kaieda, Takaaki Fukuda
exaly  

Refractory macrophage activation syndrome in a patient with SLE and APLA syndrome – Successful use of PET- CT and Anakinra in its diagnosis and treatment

Modern Rheumatology, 2015
Eldad Ben-Chetrit
exaly  

Macrophage activation syndrome in Kawasaki Disease: More common than we thought?

Seminars in Arthritis and Rheumatism, 2015
Fangqi Gong, Weihua Zhu, SongLing Fu
exaly  

Macrophage activation syndrome and cytokine-directed therapies

Best Practice and Research in Clinical Rheumatology, 2014
Grant S Schulert, Alexei A Grom
exaly  

Benefit and a possible risk of tocilizumab therapy for adult-onset Still’s disease accompanied by macrophage-activation syndrome

Modern Rheumatology, 2011
Yuko Takahashi, Hiroyuki Yamashita, Hiroshi Kaneko   +2 more
exaly  

Usefulness of soluble CD163 as a biomarker for macrophage activation syndrome associated with systemic lupus erythematosus

Lupus, 2019
A Nishino, Yasuhiro Katsumata
exaly  

Macrophage Activation Syndrome in Scleroderma

JCR: Journal of Clinical Rheumatology, 2017
Natalie Hone, Catherine Donnelly, John Brian Houk, Rina Mina   +3 more
openaire   +1 more source

Adult-onset Still’s disease with macrophage activation syndrome successfully treated with a combination of methotrexate and etanercept

Modern Rheumatology, 2012
Keisuke Maeshima
exaly